The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment

Pediatric acute lymphoblastic leukemia (ALL) affects a substantial number of children every year and requires a long and rigorous course of chemotherapy treatments in three stages, with the longest phase, the maintenance phase, lasting 2–3 years. While the primary drugs used in the maintenance phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudin, Shoshana, Marable, Marcus, Huang, R. Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414888/
https://www.ncbi.nlm.nih.gov/pubmed/28391009
http://dx.doi.org/10.1016/j.gpb.2016.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414888/
https://www.ncbi.nlm.nih.gov/pubmed/28391009
http://dx.doi.org/10.1016/j.gpb.2016.11.003

Ejemplares similares